Company

Solanbridge Group, Inc.

Headquarters: The Woodlands, TX, United States

CEO: Mr. Charles R. Shirley

OTC: SLNX

Solanbridge Group, Inc. Categories

United States Healthcare Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector:
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Detailed Description

Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Stocks & Indices

Solanbridge Group, Inc. has the following listings and related stock indices.


Stock: OTC: SLNX

Details

Headquarters:

9595 Six Pines Drive

Suite 8210

The Woodlands, TX 77380

United States

Phone: 832-225-1372

Fax: 832-201-0892